The Targeted Attack: How Peptide Receptor Radionuclide Therapy is Revolutionizing Neuroendocrine Tumor Treatment
Neuroendocrine tumors (NETs) are a diverse group of malignancies that arise from neuroendocrine cells, often presenting with slow growth but posing significant challenges due to their ability to metastasize and cause debilitating hormonal symptoms. For decades, treatment options for advanced NETs were limited. Peptide receptor radionuclide therapy (PRRT) has emerged as a game-changing...
0 Comments 0 Shares 197 Views 0 Reviews